Sentence examples for rats to determine from inspiring English sources
TIMP-1-GO was administered subcutaneously to rats to determine whether it could promote healing of the experimental wound.
The protocol was performed using Wistar rats to determine the effect of petroleum ether extract of BR leaves on blood glucose level, adipose tissue and lipid profile.
Toxicity studies of AFM were carried out in rats to determine potential toxic effects, identify potential target organs of toxicity, and determine its NOAEL.
Cryopreserved OMCSs were rapidly thawed at room temperature and wrapped around Hydroxyapatite (HA) scaffolds prior to implantation into subcutaneous sites in rats, to determine their in vivo bone-forming capability.
The expression of GABAA receptors and the effects of GABAA receptor agonists on the response properties of tongue afferent fibres were investigated in female rats to determine if peripheral GABA receptors might be a target of topical benzodiazepines when used for pain relief in burning mouth syndrome patients.
Prior to these assessments, a fluoxetine dose response function (3.2, 5.6, 10, and 18 mg/kg) was established in male Sprague Dawley rats to determine a dose of fluoxetine that would induce intermediate aversions that were comparable to those induced by 18 mg/kg cocaine (Experiment 1).
Immunohistochemistry was performed on 5 ganglia sections per rat to determine the expression of CX3CL1 and CX3CR1 on trigeminal neurons and SGCs.
We investigated the effect of GTN on evoked blinks in the anaesthetised rat to determine whether such reflexes may prove useful as the basis for a novel animal model to evaluate potential anti-migraine therapeutic agents.
For 'training', each pseudo-trained rat was yoked to a trained rat to determine the number of alley visits on each trial.
We next triple-immunostained lumbar DRG and spinal cord sections from the rat to determine if our polyclonal antibody also recognized PAP in rat tissues.
Experiments were undertaken with DMBA-induced mammary tumours of the rat to determine the anti-tumour properties of a new and potent luteinizing hormone releasing hormone (LH-RH) agonist, [D-Ser(But) 6Azgly10]-LH-RH (ICI 118630).
